Healthdirect Free Australian health advice you can count on.
Medical problem? Call 1800 022 222. If you need urgent medical help, call triple zero immediately
healthdirect Australia is a free service where you can talk to a nurse or doctor who can help you know what to do.
Emergency for Queensland, Cyclone Alfred
Due to Cyclone Alfred, health services may be disrupted in parts of Queensland and NSW. Check the healthdirect Service Finder for the latest information on health services in your area.
To seek advice or assistance in Queensland call 13 Health (13 43 25 84), otherwise call healthdirect on 1800 022 222. If you need urgent help from police, fire or ambulance services, call triple zero (000).
You should seek medical advice in relation to medicines and use only as directed by a healthcare professional.
Always read the label. If symptoms persist see your healthcare professional.
Augmentin Duo 400 oral suspension is indicated in the short term treatment of the following bacterial infections when caused by sensitive organisms (see Microbiology). Skin and skin structure infections: Urinary tract infections (complicated and uncomplicated): Upper respiratory tract infections including sinusitis, otitis media: Lower respiratory tract infections including acute exacerbations of chronic bronchitis and community acquired pneumonia. Appropriate culture and susceptibility studies should be performed to identify the causative organism(s) and determine its (their) susceptibility to Augmentin. However, when there is good reason to believe an infection may involve any of the beta-lactamase producing organisms listed above, therapy may be instituted prior to obtaining the results from bacteriological and susceptible studies. Once these results are known, therapy should be adjusted if appropriate. The treatment of mixed infections caused by amoxycillin susceptible organisms and beta-lactamase producing organisms susceptible to Augmentin Duo 400, should not require the addition of another antibiotic due to the amoxycillin content of Augmentin Duo 400.
This medicine was verified as being available on the PBS (Pharmaceutical Benefits Scheme) on March, 1 2025. To learn more about this subsidy, visit the Pharmaceutical Benefits Scheme (PBS) website.
You should seek advice from your doctor or pharmacist about taking this medicine. They can help you balance the risks and the benefits of this medicine during pregnancy.
Reporting side effects
You can help ensure medicines are safe by reporting the side effects you experience.
Augmentin Duo 400 oral suspension is indicated in the short term treatment of the following bacterial infections when caused by sensitive organisms (see Microbiology). Skin and skin structure infections: Urinary tract infections (complicated and uncomplicated): Upper respiratory tract infections including sinusitis, otitis media: Lower respiratory tract infections including acute exacerbations of chronic bronchitis and community acquired pneumonia. Appropriate culture and susceptibility studies should be performed to identify the causative organism(s) and determine its (their) susceptibility to Augmentin. However, when there is good reason to believe an infection may involve any of the beta-lactamase producing organisms listed above, therapy may be instituted prior to obtaining the results from bacteriological and susceptible studies. Once these results are known, therapy should be adjusted if appropriate. The treatment of mixed infections caused by amoxycillin susceptible organisms and beta-lactamase producing organisms susceptible to Augmentin Duo 400, should not require the addition of another antibiotic due to the amoxycillin content of Augmentin Duo 400.
You should seek advice from your doctor or pharmacist about taking this medicine. They can help you balance the risks and the benefits of this medicine during pregnancy.
Reporting side effects
You can help ensure medicines are safe by reporting the side effects you experience.
Augmentin Duo 400 oral suspension is indicated in the short term treatment of the following bacterial infections when caused by sensitive organisms (see Microbiology). Skin and skin structure infections: Urinary tract infections (complicated and uncomplicated): Upper respiratory tract infections including sinusitis, otitis media: Lower respiratory tract infections including acute exacerbations of chronic bronchitis and community acquired pneumonia. Appropriate culture and susceptibility studies should be performed to identify the causative organism(s) and determine its (their) susceptibility to Augmentin. However, when there is good reason to believe an infection may involve any of the beta-lactamase producing organisms listed above, therapy may be instituted prior to obtaining the results from bacteriological and susceptible studies. Once these results are known, therapy should be adjusted if appropriate. The treatment of mixed infections caused by amoxycillin susceptible organisms and beta-lactamase producing organisms susceptible to Augmentin Duo 400, should not require the addition of another antibiotic due to the amoxycillin content of Augmentin Duo 400.
You should seek advice from your doctor or pharmacist about taking this medicine. They can help you balance the risks and the benefits of this medicine during pregnancy.
Reporting side effects
You can help ensure medicines are safe by reporting the side effects you experience.
Government Accredited with over 140 information partners
We are a government-funded service, providing quality, approved health information and advice
Healthdirect Australia acknowledges the Traditional Owners of Country throughout Australia and their continuing
connection to land, sea and community. We pay our respects to the Traditional Owners and to Elders both past and
present.
